Viewing data from:

ISIBLOOM

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A202789 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Isibloom (2023)

Total Spending

$166K

Total Claims

5,698

Beneficiaries

1,294

Avg Cost/Unit

$0.53

Spending Trend

$162K(2019)→$192K(2020)→$206K(2021)→$175K(2022)→$166K(2023)

YoY Change:-3.5%

5yr CAGR:-3.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.15MG;0.03MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Aug 12, 2015

No patent or exclusivity listings for this strength.